Vaccines could be a new frontier in KRAS targeting
A convergence of therapeutic and technological advances reveals KRAS-targeting vaccination as a potential new approach to preventing the recurrence of pancreatic cancer, but many hurdles remain.
A convergence of therapeutic and technological advances reveals KRAS-targeting vaccination as a potential new approach to preventing the recurrence of pancreatic cancer, but many hurdles remain.